natgillin/translations-raw huggingface dataset:
In order to ensure that the cosmetic product safety report is kept up to date as required by Article 10(1)(c) of Regulation (EC) No 1223/2009, the safety of the finished product should be reassessed regularly.
Kako bi se osiguralo da je izvješće o sigurnosti kozmetičkog proizvoda ažurirano u skladu s člankom 10. stavkom 1. točkom (c) Uredbe (EZ) br. 1223/2009, sigurnost gotovog proizvoda mora se redovito procjenjivati.
When changes in the legal requirements occur (e.g. restrictions of one of the substances included in the formulation), it should be checked, amongst others (e.g. labelling), whether the formulation still complies with the law, and the safety assessment should be reviewed and, if necessary, updated.
U slučaju promjene zakonskih uvjeta (na primjer ograničenja jedne od tvari sadržane u formulaciji), između ostalog treba provjeriti (na primjer oznaku proizvoda) je li formulacija još uvijek u skladu sa zakonom, a procjenu sigurnosti treba pregledati te po potrebi i ažurirati.
The safety assessment should also be reviewed and, if necessary, updated, where one or more of the following circumstances apply:
Procjenu sigurnosti treba također preispitati te po potrebi i ažurirati u slučaju jedne ili više sljedećih okolnosti:
new scientific findings and toxicological data on the substances are available which could modify the result of the existing safety assessment;
dostupni su novi znanstveni nalazi i toksikološki podaci o tvarima te mogu promijeniti rezultat postojeće procjene sigurnosti;
changes occurring in the formulation or specifications of raw materials;
promjena u formulaciji ili specifikacijama sirovina;
changes occurring in the conditions of use;
promjena u uvjetima uporabe;
a rising trend in terms of the nature, severity and frequency of undesirable effects, both under reasonably foreseeable conditions of use and in the case of misuse [54].
rastućeg trenda u pogledu prirode, ozbiljnosti i učestalosti neželjenih posljedica, kako u razumno predvidljivim uvjetima uporabe tako i u slučaju zlouporabe [54].
Structures and processes should be established to ensure that the information relevant for the update of the cosmetic product safety report is efficiently exchanged between the responsible person and the safety assessor, and that the safety assessor is in a position to intervene where an update is necessary.
Strukture i postupci trebaju biti tako utvrđeni kako bi se osiguralo da se informacije koje su relevantne za ažuriranje izvješća o sigurnosti kozmetičkog proizvoda učinkovito razmjenjuju između odgovorne osobe i procjenitelja sigurnosti te da procjenitelj sigurnosti može posredovati ako je ažuriranje potrebno.
Assessor’s credentials and approval of Part B
Dokazi o osposobljenosti procjenitelja te njegovo odobrenje iz dijela B
The safety assessor is to be a professional with the necessary knowledge and expertise to draw up an accurate safety assessment, as indicated by the qualification requirements in Article 10(2) of Regulation (EC) No 1223/2009.
Procjenitelj sigurnosti je stručnjak koji posjeduje potrebno znanje i stručnost za provedbu točne procjene sigurnosti kao što je prikazano u zahtjevima za osposobljenost u članku 10. stavku 2. Uredbe (EZ) br. 1223/2009.
That section of the cosmetic product safety report aims at ensuring that this requirement is met and that the necessary evidence is provided.
Cilj je ovog odjeljka izvješća o sigurnosti kozmetičkog proizvoda osigurati ispunjavanje tog zahtjeva te pružanje potrebnog dokaza.
That section of the safety report is required to list the name and address of the safety assessor and to be dated and signed.
U ovom je odjeljku potrebno navesti ime i adresu procjenitelja sigurnosti te staviti datum i potpis.
The result of the safety assessment is to be signed stating the date of preparation or be issued based on an electronic release establishing a clear relationship between the assessor, the formulation and the date of assessment.
Rezultat procjene sigurnosti treba biti potpisan te treba sadržavati datum sastavljanja ili ga treba izdati u elektroničkom obliku te se treba temeljiti na jasnom odnosu između procjenitelja, formulacije i datuma procjene.
The electronic version should be protected from abuse by unauthorised persons.
Elektroničku verziju treba zaštititi od zlouporabe i pristupa neovlaštenih osoba.
In accordance with Article 10(2) of Regulation (EC) No 1223/2009, the safety assessor is required to be ‘a person in possession of a diploma or other evidence of formal qualifications awarded on completion of a university course of theoretical and practical study in pharmacy, toxicology, medicine or a similar discipline or a course recognised as equivalent by a Member State’.
U skladu s člankom 10. stavkom 2. Uredbe (EZ) br. 1223/2009, procjenitelj sigurnosti jest „osoba koja posjeduje diplomu ili neki drugi dokaz o stručnoj osposobljenosti, koji joj se dodjeljuje po završetku sveučilišnog teoretskog i praktičnog studija farmacije, toksikologije, medicine ili slične discipline ili studija koji se u državi članici priznaje kao jednakovrijedan”.
A person who has obtained qualifications in a third country may act as a safety assessor if they have completed ‘a course recognised as equivalent [to a university course of theoretical and practical study in pharmacy, toxicology, medicine or a similar discipline] by a Member State’.
Osoba koja je stekla osposobljenost u trećoj zemlji može djelovati u svojstvu procjenitelja sigurnosti ako ima završen „studij koji dotična država članica priznaje kao jednakovrijedan [teoretskom i praktičnom sveučilišnom studiju farmacije, toksikologije, medicine ili slične discipline]”.
Proof is to be provided of the safety assessor’s qualification (i.e. copy of the diploma and, where needed, proof of equivalence) laid down in Article 10 of Regulation (EC) No 1223/2009.
Treba pružiti dokaz o osposobljenosti procjenitelja sigurnosti (primjerice presliku diplome te po potrebi dokaz o ekvivalentnosti) u skladu s člankom 10. Uredbe (EZ) br. 1223/2009.
European Chemicals Agency (ECHA), Guidance on information requirements and chemical safety assessment — Chapter R.7a: Endpoint specific guidance, May 2008.
European Chemicals Agency (ECHA), Guidance on information requirements and chemical safety assessment - Chapter R.7a: Endpoint specific guidance, May 2008.
European Chemicals Agency (ECHA), Guidance on information requirements and chemical safety assessment — Chapter R.7c: Endpoint specific guidance, May 2008.
European Chemicals Agency (ECHA), Guidance on information requirements and chemical safety assessment - Chapter R.7c: Endpoint specific guidance, May 2008.
Regulatory Toxicology and Pharmacology 25 (1997), p. 1-5.
Regulatory Toxicology and Pharmacology 25 (1997), str. 1-5.
SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks), Opinion on the scientific basis for the definition of the term ‘nanomaterial’, 8 December 2010.
SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks), Opinion on the scientific basis for the definition of the term „nanomaterial”, 8 December 2010.
Article 11(2) of Regulation (EC) No 1223/2009.
Članak 11. stavak 2. Uredbe (EZ) br. 1223/2009.
Article 10(1) of Regulation (EC) No 1223/2009.
Članak 10. stavak 1. Uredbe (EZ) br. 1223/2009.
Article 10(1)(c) of Regulation (EC) No 1223/2009.
Članak 10. stavak 1. točka (c) Uredbe (EZ) br. 1223/2009.
The SCCS’s Notes of Guidance for the Testing of Cosmetic Ingredients and their Safety Evaluation, 8th Revision, SCCS/1501/12, and its subsequent updates.
Smjernice SCCS-a za ispitivanje kozmetičkih sastojaka i njihovu sigurnosnu evaluaciju, 8. revizija, SCCS/1501/12, i njihova naknadna ažuriranja.
SCCS Notes of Guidance, para. 3-6.2, pp. 35-36.
Smjernice SCCS-a, stavak 3-6.2., str. 35.-36.
This point is relevant in the context of Good Manufacturing Practices, and is explicitly addressed by the relevant standard EN ISO 22716:2007.
Ovo je stajalište relevantno u kontekstu dobre proizvodne prakse te se na njega izričito primjenjuje predmetni standard EN ISO 22716:2007.
More specifically, it matches the requirements for the release of raw materials and the finished product.
U određenijem smislu, odgovara zahtjevima za oslobađanjem sirovina i gotovog proizvoda.
See section 3.3 on Microbiological quality.
Vidjeti odjeljak 3.3. o Mikrobiološkoj kakvoći.
See ‘Practical implementation of Article 6(1)(c) of the Cosmetics Directive (76/768/EEC): Labelling of product durability: “period of time after opening” ’ (Council Directive 76/768/EEC, OJ L 262, 27.9.1976, p. 169) http://ec.europa.eu/consumers/sectors/cosmetics/files/doc/wd-04-entr-cos_28_rev_version_adoptee20040419_en.pdf
Vidjeti „Praktičnu provedbu članka 6. stavka 1. točke (c) Direktive o kozmetičkim proizvodima (76/768/EEZ): OZNAKA ROKA TRAJANJA PROIZVODA: ‚TRAJANJE NAKON OTVARANJA’ ” (Direktiva Vijeća 76/768/EEZ, SL L 262. 27.9.1976., str. 169.) na internetskim stranicama http://ec.europa.eu/consumers/sectors/cosmetics/files/doc/wd-04-entr-cos_28_rev_version_adoptee20040419_en.pdf
SCCS Notes of Guidance, para. 4-3.3, p. 74.
Smjernice SCCS-a, stavak 4-3.3., str. 74.
The ‘date of minimum durability’ is the date until which the cosmetic product, stored under appropriate conditions, will continue to fulfil its initial function and, in particular, will remain safe; the PAO is the period of time after opening for which the product can be used without any harm to the consumer.
„Najkraći rok trajanja” jest datum do kojeg će kozmetički proizvod, skladišten u prikladnim uvjetima, i dalje ispunjavati svoju početnu funkciju i posebno će ostati siguran; trajanje nakon otvaranja (PAO) jest vremensko razdoblje nakon otvaranja tijekom kojeg se proizvod može upotrebljavati, a da nije štetan za potrošača.
See ‘Practical implementation of Article 6(1)(c) of the Cosmetics Directive (76/768/EEC): Labelling of product durability: “period of time after opening” ’.
Vidjeti „Praktičnu provedbu članka 6. stavka 1. točke (c) Direktive o kozmetičkim proizvodima (76/768/EEZ): OZNAKA ROKA TRAJANJA PROIZVODA: ‚TRAJANJE NAKON OTVARANJA’ ”.
SCCS Notes of Guidance, para 4-4, pp. 75–76.
Smjernice SCCS-a, stavak 4-4., str. 75.-76.
Article 17 of Regulation (EC) No 1223/2009 establishes that traces of prohibited substances are only permitted if they are technically unavoidable and if they have no impact on the safety of the cosmetic products.
Člankom 17. Uredbe (EZ) br. 1223/2009 utvrđuje se da su zabranjene tvari u tragovima jedino dopuštene ako su tehnički neizbježne te ako nemaju učinak na sigurnost kozmetičkih proizvoda.
The ‘non-threshold genotoxic and carcinogenic substances’ are the genotoxic and carcinogenic substances without a threshold for the carcinogenic-genotoxic effects.
„Genotoksične i karcinogene tvari bez praga” jesu genotoksične i karcinogene tvari bez praga za karcinogeno-genotoksične učinke.
Opinion of the Scientific Committee on a request from EFSA related to A Harmonised Approach for Risk Assessment of Substances Which are both Genotoxic and Carcinogenic, the EFSA Journal (2005) 282, pp. 1-31.
Mišljenje Znanstvenog odbora o zahtjevu Europske agencije za sigurnost hrane (EFSA) vezanom uz usklađeni pristup procjene rizika za tvari koje su kako genotoksične tako i karcinogene, Službeni list EFSA-e (2005) 282, str. 1.-31.
OJ L 338, 13.11.2004, p. 4.
SL L 338, 13.11.2004., str. 4.
To evaluate the risk, one needs to consider the hazard together with the exposure, and this is the duty of the safety assessor.
Za procjenu rizika potrebno je razmotriti opasnost zajedno s izloženošću, a to je dužnost procjenitelja sigurnosti.
SCCS Notes of Guidance, para 4, p. 66 et seq.
Smjernice SCCS-a, stavak 4., str. 66. et seq.
M. Pauwels, V. Rogiers, Human Health Safety Evaluation of Cosmetics in the EU: A Legally Imposed Challenge to Science, Toxicology and Applied Pharmacology, 243 (2010), p. 261.
M. Pauwels, V. Rogiers, Human Health Safety Evaluation of Cosmetics in the EU: A Legally Imposed Challenge to Science, Toxicology and Applied Pharmacology, 243 (2010), str. 261.
Communication from the Commission to the European Parliament and the Council on the animal testing and marketing ban and on the state of play in relation to alternative methods in the field of cosmetics, COM(2013) 135 final.
Komunikacija Komisije Europskom parlamentu i Vijeću o ispitivanju na životinjama i zabrani stavljanja na tržište te stanju stvari u odnosu na alternativne metode u području kozmetičke industrije, COM(2013) 135 završna verzija.
See in particular point 3.1 of the Communication.
Vidjeti posebno točku 3.1. Komunikacije.
OJ L 142, 31.5.2008, p. 1.
SL L 142, 31.5.2008., str. 1.
SCCS Notes of Guidance, para. 3.4.11.
Smjernice SCCS-a, stavak 3.4.11.
Also cf. opinions SCCNFP/0068/98, an earlier version of the Notes of Guidance, and SCCNFP/0245/99 on Basic Criteria of the Protocols for the Skin Compatibility Testing of Potentially Cutaneous Irritant Cosmetic Ingredients or Mixtures of Ingredients on Human Volunteers.
Također usporediti mišljenja Znanstvenog odbora za kozmetičke proizvode i neprehrambene proizvode namijenjene potrošačima SCCNFP/0068/98, prijašnju verziju smjernica te SCCNFP/0245/99 o osnovnim kriterijima protokola za ispitivanje na dobrovoljcima kompatibilnosti s kožom kozmetičkih sastojaka ili smjesa koji mogu nadražiti kožu.
Read-across is a technique for data gap filling in which information for one or more source chemicals is used to make a prediction for a target chemical, which is considered to be similar in some way.
Read-across jest tehnika za popunjavanje praznina u podacima u kojoj se koriste podaci za jednu ili više izvornih kemikalija u svrhu predviđanja ciljne kemikalije, koja se na neki način smatra sličnom.
From ECHA, ‘Guidance on information requirements and chemical safety assessment Chapter R.4: Evaluation of available information’, December 2011, p. 12. http://echa.europa.eu/documents/10162/17235/information_requirements_r4_en.pdf
Iz „Smjernica ECHA-e o zahtjevima obavješćivanja i procjeni kemijske sigurnosti - poglavlje R.4: Evaluacija raspoloživih podataka”, prosinac 2011., str. 12. http://echa.europa.eu/documents/10162/17235/information_requirements_r4_en.pdf
One definition for weight of evidence is: ‘the process of considering the strengths and weaknesses of various pieces of information in reaching and supporting a conclusion concerning a property of the substance.’ From ECHA, ‘Practical guide 2: How to report weight of evidence’, 2010, p. 2, http://echa.europa.eu/documents/10162/13655/pg_report_weight_of_evidence_en.pdf
Jedna definicija ocjenjivanja dokazne snage jest: „postupak razmatranja jakosti i slabosti različitih podataka u cilju postizanja i podržavanja zaključka o svojstvu tvari”. Iz „Praktičnog vodiča 2 ECHA-e: Kako obavještavati o ocjenjivanju dokazne snage”, 2010., str. 2. http://echa.europa.eu/documents/10162/13655/pg_report_weight_of_evidence_en.pdf
The SCCS Notes of Guidance clearly address this issue in para. 3-6.1 General toxicological requirements.
Smjernice SCCS-a jasno ukazuju na taj problem u stavku 3-6.1. Općih toksikoloških zahtjeva.
According to the SCCS’s Notes of Guidance (para. 3-4.5), priority should be given to the NOAEL as regards sub-chronic toxicity (90 day study).
Prema Smjernicama SCCS-a (stavak 3-4.5.), prednost treba dati razini bez zapažene štetne posljedice (NOAEL) što se tiče subkronične toksičnosti (90-dnevno ispitivanje).
Only if such values are not available should results relating to sub-acute toxicity (28-day study) be used.
Samo ako te vrijednosti nisu dostupne, koriste se rezultati vezani uz subakutnu toksičnost (28-dnevno ispitivanje).
ECHA, Guidance on information requirements and chemical safety assessment — Chapter R.7a: Endpoint specific guidance, May 2008.
Smjernice ECHA-e o zahtjevima obavješćivanja i procjeni kemijske sigurnosti - poglavlje R.7.a: Endpoint specific guidance, May 2008.
Cfr. ECHA, Guidance for identification and naming of substances under REACH and CLP, November 2011, p. 29. http://echa.europa.eu/documents/10162/17235/substance_id_en.pdf
Usporedite Smjernice ECHA-e za identifikaciju i nazive tvari prema uredbama REACH i CLP, studeni 2011., str. 29. http://echa.europa.eu/documents/10162/17235/substance_id_en.pdf
I.e.‘the systemically available dose that passes the relevant physical barriers (gastro-intestinal, skin or lung structures) and becomes available in the blood stream for subsequent distribution to tissues and organs’, ref. M. Pauwels, V. Rogiers, p. 262.
Tj.„sustavno raspoloživa doza koja prelazi odgovarajuće fizičke barijere (gastrointestinalne, kožne ili plućne strukture) te dolazi u krv kako bi se putem protoka krvi dalje distribuirala u tkivo i organe”, ref. M. Pauwels, V. Rogiers, str. 262.
Basic criteria for the in vitro assessment of dermal absorption of cosmetic ingredients (SCCS/1358/10).
Temeljni kriteriji za procjenu in vitro dermalne apsorpcije kozmetičkih sastojaka (SCCS/1358/10).
SCCS Notes of Guidance, para 3-7.2, p. 49.
Smjernice SCCS-a, stavak 3-7.2., str. 49.
M. Pauwels, V. Rogiers, p. 262.
M. Pauwels, V. Rogiers, str. 262.
SCCS Note of Guidance, para 3-7, p. 46.
Smjernice SCCS-a, stavak 3-7., str. 46.
IGHRC, Guidelines on route-to-route extrapolation of toxicity data when assessing health risks of chemicals.
Smjernice IGHRC-a o ekstrapolaciji (route-to route) podataka o toksičnosti pri procjeni zdravstvenih rizika kemikalija.
See for example: SCCS (Scientific Committee on Consumer Safety), Guidance on safety assessment of nanomaterials in cosmetics, SCCS/1484/12; SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks), Opinion on the scientific basis for the definition of the term ‘nanomaterial’, 8 December 2010.
Vidjeti primjer: Smjernice Znanstvenog odbora za zaštitu potrošača (SCCS) o procjeni sigurnosti primjene nanomaterijala u kozmetičkoj industriji, SCCS/1484/12; SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks), Opinion on the scientific basis for the definition of the term „nanomaterial”, 8. prosinca 2010.
R. Kroes, A. G. Renwick, V. Feron, C. L. Galli, M. Gibney, H. Greim, R. H. Guy, J. C. Lhuguenot, J. J. M. van de Sandt, Application of the threshold of toxicological concern (TTC) to the safety evaluation of cosmetic ingredients, Food and Chemical Toxicology 45 (2007), pp. 2533–2562.
R. Kroes, A. G. Renwick, V. Feron, C. L. Galli, M. Gibney, H. Greim, R. H. Guy, J. C. Lhuguenot, J. J. M. van de Sandt, Application of the threshold of toxicological concern (TTC) to the safety evaluation of cosmetic ingredients, Food and Chemical Toxicology 45 (2007), str. 2533.–2562.
Several publicly available databases containing toxicological data on substances used in cosmetics exist, and are listed in the Appendix to this Guideline.
Postoji nekoliko javno dostupnih baza podataka koje sadrže toksikološke podatke o tvarima upotrijebljenima u kozmetičkoj industriji te su navedene u Dodatku ovim Smjernicama.
OJ L 353, 31.12.2008, p. 1, and ECHA’s registration website: http://apps.echa.europa.eu/registered/registered-sub.aspx
SL L 353, 31.12.2008., str. 1., i internetske stranice za registraciju Europske agencije za kemikalije: http://apps.echa.europa.eu/registered/registered-sub.aspx
This is a consequence of the requirement of Article 23 of Regulation (EC) No 1223/2009, which establishes the obligation for responsible persons to notify serious undesirable effects to competent authorities in the EU Member States.
To proizlazi iz zahtjeva utvrđenog u članku 23. Uredbe (EZ) br. 1223/2009, u kojem se utvrđuje obveza prema kojoj su odgovorne osobe dužne obavijestiti nadležne vlasti u državama članicama EU-a o ozbiljnim neželjenim posljedicama.
Article 23 of Regulation (EC) No 1223/2009.
Članak 23. Uredbe (EZ) br. 1223/2009.
For undesirable effects that are very likely or likely to be attributable to the cosmetic product, Article 21 of Regulation (EC) No 1223/2009, ‘Access to information for the public’, applies.
Članak 21. Uredbe (EZ) br. 1223/2009., „Pristup podacima za javnost”, primjenjuje se na neželjene posljedice koje se vrlo vjerojatno ili vjerojatno pripisuju kozmetičkom proizvodu.
European Commission, Serious Undesirable Effects (SUE) Reporting Guidelines, http://ec.europa.eu/consumers/sectors/cosmetics/files/pdf/sue_reporting_guidelines_en.pdf
Smjernice Europske komisije o obavješćivanju o ozbiljnim neželjenim posljedicama (SUE) mogu se pronaći na internetskoj stranici:http://ec.europa.eu/consumers/sectors/cosmetics/files/pdf/sue_reporting_guidelines_en.pdf
This is an obligation of the responsible person according to article 10(1)(c) of Regulation (EC) No 1223/2009.
To je obveza odgovorne osobe iz članka 10. stavka 1. točke (c) Uredbe (EZ) br. 1223/2009.
OJ L 265, 26.9.2006, p. 39.
SL L 265, 26.9.2006., str. 39.
Available on http://ec.europa.eu/consumers/sectors/cosmetics/documents/guidelines/labelling/index_en.htm
Dostupno na internetskim stranicama http://ec.europa.eu/consumers/sectors/cosmetics/documents/guidelines/labelling/index_en.htm
Available on http://ec.europa.eu/consumers/sectors/cosmetics/files/doc/guide_labelling200802_en.pdf
Dostupno na internetskim stranicama http://ec.europa.eu/consumers/sectors/cosmetics/files/doc/guide_labelling200802_en.pdf
For products in the same range, where the only difference among different products is the colouring agent, and that has no impact on safety, e.g. for lipsticks or other colour make-up, a combined product safety report may be considered, but is to be justified.
Za proizvode u istoj paleti, ako se različiti proizvodi jedino razlikuju po bojilu koje nema utjecaja na sigurnost, na primjer za ruževe za usne ili drugu obojenu šminku, izvješće o sigurnosti kombiniranog proizvoda (takozvani opći postupak) može se razmotriti, ali se mora obrazložiti.
SCCS, SCHER, SCENIHR, Toxicity and Assessment of Chemical Mixtures, 2012 http://ec.europa.eu/health/scientific_committees/environmental_risks/docs/scher_o_155.pdf
Toksičnost i procjena kemijskih smjesa, 2012., SCCS-a, SCHER-a i SCENIHR-a http://ec.europa.eu/health/scientific_committees/environmental_risks/docs/scher_o_155.pdf
SCCS Notes of Guidance, para 3-7.3, p. 51.
Smjernice SCCS-a, stavak 3-7.3., str. 51.
The product information file should be updated when necessary and kept readily accessible, in electronic or other format, at the address of the responsible person given on the label, to the competent authorities for market surveillance purposes for a period of 10 years following the placing on the market of the last batch of the product.
Dokumentacija s podacima o proizvodu treba se po potrebi ažurirati te biti na raspolaganju nadležnim tijelima za potrebe nadzora nad tržištem, u elektroničkom ili drugom obliku, na adresi odgovorne osobe koja se navodi na oznaci proizvoda, u trajanju od deset godina od stavljanja posljednje serije proizvoda na tržište.
The most important element of the product information file, from a safety point of view, is the cosmetic product safety report referred to in Article 10(1).
Najvažniji element dokumentacije s podacima o proizvodu sa sigurnosnog stanovišta jest izvješće o sigurnosti kozmetičkog proizvoda iz članka 10. stavka 1.
Klimisch, E. Andreae and U. Tillmann (1997), A systematic approach for evaluating the quality of experimental and ecotoxicological data.
Klimisch, E. Andreae i U. Tillmann (1997), A systematic approach for evaluating the quality of experimental and ecotoxicological data.
Cfr.
Usporedite Smjernice SCCS-a, odjeljak 3-6.
SCCS Notes of Guidance, Section 3-6 Basic Requirements for Cosmetic Substances Present in Finished Cosmetic Products (which are to be evaluated by individual safety assessors).
Osnovni zahtjevi za kozmetičke tvari koje su prisutne u gotovim kozmetičkim proizvodima (koje trebaju procijeniti pojedini ocjenitelji sigurnosti).